Callidus Biopharma, Inc. — Form D/A
Callidus Biopharma, Inc. of DOYLESTOWN, PA, a company, filed a Form D amendment with the SEC on 2013-03-19. The offering totals $5.0M, of which $3.6M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2013-03-19
- Form: D/A
- Accession: 0000930413-13-001731
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $5.0M
- Amount sold: $3.6M
- Remaining: $1.4M
- Minimum investment: $20K
- Investors: 8
- Date of first sale: 2012-01-04
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-172083
Issuer
- Name: Callidus Biopharma, Inc.
- CIK: 0001539849
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
- Phone: 215-434-7482
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Cuong Do | Director | DOYLESTOWN, PA |
| Cuong Do | Executive Officer | DOYLESTOWN, PA |
Other filings by this issuer (3)
More